CD40 expression on graft infiltrates and parenchymal CD154 (CD40L) induction in human chronic renal allograft rejection

Kidney International

Volumn 55, Issue 4, 1999, Pages 1543-1552

  Gaweco, Anderson S ^a,b   Mitchell, Bonnie L ^a,b   Lucas, Bruce A ^a,b   McClatchey, Kenneth D ^a,b   Van Thiel, David H ^a,b  

^a LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF KENTUCKY MEDICAL CENTER   (United States)

Author keywords

Alloimmune response; CD40 CD154; Chronic rejection; End stage renal disease; Graft rejection; Signaling; Transplantation

Indexed keywords

CD40 ANTIGEN; CD68 ANTIGEN; T LYMPHOCYTE RECEPTOR;

ANTIGEN EXPRESSION; ARTICLE; CLINICAL ARTICLE; EFFECTOR CELL; GLOMERULUS; GRAFT REJECTION; HUMAN; HUMAN TISSUE; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; KIDNEY ALLOGRAFT; KIDNEY BIOPSY; MACROPHAGE; MESANGIUM CELL; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

EID: 0032944937     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.1999.00379.x     Document Type: Article

References (49)

1. SCHWEITZER EJ, MATAS AJ, GILLINGHAM KJ, PAYNE WD, GORES PF, DUNN DL, SUTHERLAND DE, NAJARIAN JS: Causes of renal allograft loss: Progress in the 1980s, challenges for the 1990s. Ann Surg 214:679-688, 1991
2. HAYRY P, ISONIEMI H, YILMAZ S, MENNANDER A, LEMSTROM K, RAISANEN-SOKOLOWSKI A, KOSKINEN P, USTINOV J. LAUTEN-SCHLACER I, TASKINEN E, KROGERUS L, AHU P, PAAVONEN T: Chronic allograft rejection. Immunol Rev 134:33-81, 1993
3. ADAMS DH, RUSSELL. ME, HANCOCK WW, SAYEGH MH, WYNER LR, KARNOVSKY MJ: Chronic rejection in experimental cardiac transplantation: Studies in the Lewis-F344 model. Immunol Rev 134:5-19, 1993
4. TULLIUS SG, TILNEY NL: Both alloantigen-dependent and -independent factors influence chronic allograft rejection. Transplantation 59:313-318, 1995
5. HANCOCK WH, WHITLEY WD, TULLIUS SG, HEEMANN UW, WASOWSKA B, BALDWIN WM, TILNEY NL: Cytokines, adhesion molecules, and the pathogenesis of chronic rejection of rat renal allografts. Transplantation 56:643-650, 1993
6. TULLIUS SG, HANCOCK WW, HEEMANN U, AZUMA H, TILNEY NL: Reversibility of chronic renal allograft rejection: Critical effect of lime after transplantation suggests both host immune dependent and independent phases of progressive injury. Transplantation 58:93-99, 1994
7. AZUMA H, BINDER J, HEEMANN U, SCHMID C, TULLIUS SG, TILNEY NL: Effects of RS61443 on functional and morphological changes in chronically rejecting rat kidney allografts. Transplantation 59:460-466, 1995
8. RUSSELL ME, WALLACE AF, HANCOCK WW, SAYEGH MH, ADAMS DH, SIBINGA NE, WYNER LR, KARNOVSKY MJ: Upregulation of cytokines associated with macrophage activation in the Lewis-to-F344 rat transplantation model of chronic cardiac rejection. Transplantation 59:572-578, 1995
9. PEARSON TC, ALEXANDER DZ, WINN KJ, LINSLEY PS, LOWRY RP, LARSEN CP: Transplantation tolerance induced by CTLA4-Ig. Transplantation 57:1701-1706, 1994
10. SAYEGH MH, AKALIN E, HANCOCK WW, RUSSELL ME, CARPENTER CB, LINSLEY PS, TURKA LA: CD28-B7 blockade after alloantigenic challenge in vivo inhibits Th1 cytokines hut spares Th2. J Exp Med 181:1869-1874, 1995
11. LARSEN CP, ELWOOD ET, ALEXANDER DZ, RITCHIE SC, HENDRIX R, TUCKER-BURDEN C, CHO HR, ARUFFO A, HOLLENBAUGH D, LINSLEY PS, WINN KJ, PEARSON TC: Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways. Nature 381:434-438, 1996
12. LARSEN CP, ALEXANDER DZ, HOLLENBAUGH D, ELWOOD ET, RITCHIE SC, ARUFFO A, HENDRIX R, PEARSON TC: CD40-gp39 interactions play a critical role during allograft rejection: Suppression of allograft rejection by blockade of the CD40-gp39 pathway. Transplantation 61:4-9, 1996
13. SUN H, SUBBOTIN V, CHEN C, AITOUCHE A, VALDIVA LA, SAYEGH MH, LINSLEY PS, FUNG JJ, STARZL TE, RAO AS: Prevention of chronic rejection in mouse aortic allografts by combined treatment with CTLA4-Ig and anti-CD40 ligand monoclonal antibody. Transplantation 64:1838-1843, 1997
14. KIRK AD, HARLAN DM, ARMSTRONG NN, DAVIS TA, DONG Y, GRAY GS, HONG X, THOMAS D, FECHNER JHJ, KNECHTLE SJ: CTLA4-Ig and anti-CD40 ligand prevent renal allograft rejection in primates. Proc Natl Acad Sci USA 94:8789-8794, 1997
15. SOLEZ K, AXELSEN RA, BENEDIKTSSON H, BURDICK JF, COHEN AH, COLVIN RB, CROKER BP, DROZ D, DUNNILL MS, HALLORAN PF, HAYRY P, JENNETTE JC, KEOWN PA, MARCUSSEN N, MIHATSCH MJ, MOROZUMI K, MYERS BD, NAST CC, OLSEN S, RACUSEN LC, RAMOS EL, ROSEN S, SACHS DH, SALOMEEN DR, SANFILIPPO F, VERANI R, VON WILLEBRAND R, YAMAGUCHI Y: International standardization of criteria for the histologic diagnosis of renal allograft rejection: The Banff working classification of kidney transplant pathology. Kidney Int 44:411-422, 1993
16. SOLEZ K, BENEDIKTSSON H, CAVALLO T, CROKER B, DEMETRIS AJ, DRACHENBERG C, EMANCIPATOR S, FURNESS PN, GABER LW, GIBSON IW, GOUGH J, GUPTA R, HALLORAN P, HAYRY P, KASHGARIAN M, MARCUSSEN N, MASSY ZA, MIHATSCH MJ, MOROZUMI K, NORONHA I, OLSEN S, PAPADIMITRIOU J, PAUL LC, PICKEN M, RACUSEN LC: Report of the Third Banff Conference on Allograft Pathology (July 20-24, 1995) on classification and lesion scoring in renal allograft pathology. Transplant Proc 28:441-444, 1996
17. ANDREW SM, JASANI B: An improved method for the inhibition of endogenous peroxidase non-deleterious to lymphocyte surface markers: Application to immunoperoxidase studies on cosinophilrich tissue preparations. Histochem J 19:426-430, 1987
18. VAN GOOL SW, VANDENBERGHE P, DE BOER M, CEUPPENS JL: CD80, CD86 and CD40 provide accessory signals in a multiple-step T-cell activation model. Immunol Rev 153:47-83, 1996
19. LARSEN CP, PEARSON TC: The CD40 pathway in allograft rejection, acceptance, and tolerance. Curr Opin Immunol 9:641-647, 1997
20. FOY TM, ARUFFO A, BAJORATH J, BUHLMANN JE, NOELLE RJ: Immune regulation by CD40 and its ligand GP39. Annu Rev Immunol 14:591-617, 1996
21. GREWAL IS, FLAVELL RA: CD40 and CD154 in cell-mediated immunity. Annu Rev Immunol 16:111-135, 1998
22. DENTON MD, REUL RM, DHARNIDHARKA VR, FANG JC, GANZ P, BRISCOE DM: Central role for CD40/CD40 ligand (CD 154) interactions in transplant rejection. Pediatr Transplant 2:6-15, 1998
23. VAN KOOTEN C, GERRTTSMA JS, PAAPE ME, VAN Es EL, BANCHEREAU J, DAHA MR: Possible role for CD40-CD40L in the regulation of interstitial infiltration in the kidney. Kidney Int 51:711-721, 1997
24. ZHENG XX, SCHACHTER AD, VASCONELLOS L, STREHLAU J, TIAN Y, SHAPIRO M, HARMOS W, STROM TB: Increased CD40 ligand gene expression during human renal and murine islet allograft rejection. Transplantation 65:1512-1515, 1998
25. YELLIN MJ, D'AGATL V, PARKINSON G, HAN AS, SZEMA A, BAUM D, ESTES D, SZABOLCS M, CHESS L: Immunohistologic analysis of renal CD40 and CD40L expression in lupus nephritis and other glomerulonephritides. Arthritis Rheum 40:124-134, 1997
26. PINCHUK LM, KLAUS SJ, MAGALETTI DM, PINCHUK GV, NORSEN JP, CLARK EA: Functional CD40 ligand expressed by human blood dendritic cells is up-regulated by CD40 ligation. J Immunol 157:4363-4370, 1996
27. MACH F, SCHONBECK U, SUKHOVA GK, BOURCIER T, BONNEFOY JY, POBER JS, LIBBY P: Functional CD40 ligand is expressed on human vascular endothelial cells, smooth muscle cells, and macrophages: Implications for CD40-CD40 ligand signaling in atherosclerosis. Proc Natl Acad Sci USA 94:1931-1936, 1997
28. REUL RM, FANG JC, DENTON MD, GEEHAN C, LONG C, MITCHELL RN, GANZ P, BRISCOE DM: CD40 and CD40 ligand (CD 154) are coexpressed on microvessels in vivo in human cardiac allograft rejection. Transplantation 64:1765-1774, 1997
29. LUDEWIG B, HENN V, SCHRODER JM, GRAF D, KROCZEK RA: Induction, regulation, and function of soluble TRAP (CD40 ligand) during interaction of primary CD4+ CD45RA + T cells with dendritic cells. Eur J Immunol 26:3137-3143, 1996
30. PIETRAVALLE F, LECOANET-HINCHOZ S, AUBRY JP, ELSON G, BONNEFOY JY, GAUCHAT JF: Cleavage of membrane-bound CD40 ligand is not required fur inducing B cell proliferation and differentiation. Eur J Immunol 76:725-728, 1996
31. GRAF D, MULLER S, KORIHAUER U, VAN KOOTEN C, WEISE C, KROCZEK RA: A soluble form of TRAP (CD40 ligand) is rapidly released after T cell activation. Eur J Immunol 25:1749-1754, 1995
32. KIENER PA, MORAN-DAVIS P, RANKIN BM, WAHL AF, ARUFFO A, HOLLENBAUGH D: Stimulation of CD40 with purified soluble gp39 induces proinflammatory responses in human monocytes. J Immunol 155:4917-4925, 1995
33. FANSLOW WC, CLIFFORD KN, SEAMAN M, ALDERSON MR, SPRIGGS MK, ARMITAGE RJ, RAMSDELL F: Recombinant CD40 ligand exerts potent biologic effects on T cells. J Immunol 152:4262-4269, 1994
34. ALDERSON MR, ARMITAGE RJ, TOUGH TW, STROCKBINE L, FANSLOW WC, SPRIGGS MK: CD40 expression by human monocytes: Regulation by cytokines and activation of monocytes by the ligand for CD40. J Exp Med 178:669-674, 1993
35. ARMITAGE RJ, TOUGH TW, MACDUFF BM, FANSLOW WC, SPRIGGS MK, RAMSDELL F, ALDERSON MR: CD40 ligand is a T cell growth factor. Eur J Immunol 23:2326-2331, 1993
36. HANCOCK WW, SAYEGH MB, ZHENG XG, PEACH R, LINSLEY PS, TURKA LA: Costimulatory function and expression of CD40 ligand, CD80, and CD86 in vascularized murine cardiac allograft rejection. Proc Natl Acad Sci USA 93:13967-13972, 1996
37. SUTTLES J, EVANS M, MILLER RW, POE JC, STOUT RD, WAHL LM: T cell rescue of monocytes from apoptosis: Role of the CD40 CD40L interaction and requirement for CD40-mediated induction of protein tyrosine kinase activity. J Leukoc Biol 60:651-657, 1996
38. HSING Y, HOSTAGER BS, BISHOP GA: Characterization of CD40 signaling determinants regulating nuclear factor-kappa B activation in B lymphocytes. J Immunol 159:4898-4906, 1997
39. BAICHWAL VR, BAEUERLE PA: Activate NF-kappa B or die? Curr Biol 7:R94-R96, 1997
40. SCHAUER SL, WANG Z, SONENSHEIN GE, ROTHSTEIN TL: Maintenance of nuclear factor-kappa B/Rel and c-myc expression during CD40 ligand rescue of WEHI 231 early B cells from receptor-mediated apoptosis through modulation of 1 kappa B proteins. J Immunol 157:81-86, 1996
41. KERBY JD, VERRAN DJ, LUO KL, DING Q, TAGOURI Y, HERRERA GA, DIETHELM AG, THOMPSON JA: Immunolocalization of FGF-1 and receptors in glomerular lesions associated with chronic human renal allograft rejection. Transplantation 62:190-200, 1996
42. VUILLEMIN T, LEGENDRE C, MEDURI G, LARUE JR, GOUPY C, KRIAA F, HIESSE C, BENOTT G, SENIK A, KREIS H, CHARPENTIER B: In situ expression of cell growth factors in human renal chronic graft rejection. Transplant Proc 29:1513-1514, 1997
43. SHARMA VK, BOLOGA RM, LI B, XU GP, LAGMAN M, HISCOCK W, MOURADIAN J, WANG J, SERUR D, RAO VK, SUTHANTHIRAN M: Molecular executors of cell death: Differential intrarenal expression of Fas ligand. Fas, granzyme B, and perforin during acute and/or chronic rejection of human renal allografts. Transplantation 62:1860-1866, 1996
44. SHARMA VK, BOLOGA KM, XU GP, LI B, MOURADIAN J, WANG J, SERUR D, RAO V, SUTHANTHIRAN M: Intragraft TGF-beta 1 mRNA: A correlate of interstitial fibrosis and chronic allograft nephropathy. Kidney Int 49:1297-1303, 1996
45. ISHIBASHI M, AZUMA H, TILNEY NL: Prevention of chronic rejection of renal allografts in rats using a synthetic inhibitor of macrophage effector activation. Transplant Proc 27:564-565, 1995
46. VAN ESSEN D, KIKUTANI H, GRAY D: CD40 ligand-transduced co-stimulation of T cells in the development of helper function. Nature 378:620-623, 1995
47. BLOTTA MH, MARSHALL JD, DEKRUYFF RH, UMETSU DT: Cross-linking of the CD40 ligand on human CD4+ T lymphocytes generates a costimulatory signal that up-regulates IL-4 synthesis. J Immunol 156:3133-3140, 1996
48. BRENNER B, KOPPENHOEFER U, LEPPLE-WIENHUES A, GRASSME H, MULLER C, SPEER CP, LANG F, GULBINS E: The CD40 ligand directly activates T-lymphocytes via tyrosine phosphorylation dependent PKC activation. Biochem Biophys Res Commun 239:11-17, 1997
49. TRUONG LD, SHAPPELL S, BARRIOS R, GONZALEZ J, SUKI W, SOLEZ K: Immunohistochemistry and molecular biology markers of renal transplant rejection: diagnostic applications. Transplantation Rev 10:187-208, 1998